Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-855-9 | CAS number: 925430-39-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant guideline study, available as unpublished report, no restriction, fully adequate for assesment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Qualifier:
- according to guideline
- Guideline:
- other: Japan MAFF Testing Guideline of 12 Nosan No. 8147
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bioassay Labor fur biologische Analytik GmbH, INF 515, 69120 Heidelberg
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 3-[(1R)-2-chloro-1-hydroxyethyl]phenol
- EC Number:
- 618-855-9
- Cas Number:
- 925430-39-3
- Molecular formula:
- C8 H9 Cl O2
- IUPAC Name:
- 3-[(1R)-2-chloro-1-hydroxyethyl]phenol
- Details on test material:
- - Name of the test substance used in the study report: 2-Chlor-1-(3-hydroxyphenyl)-ethanol
- Physical state: Solid
- Homogeneity: The test substance was homogeneous by visual inspection
- Storage condition of test material: Room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Sandhofer Weg 7, 97633 Sulzfeld, Germany
- Age at study initiation: ca 10 weeks
- Weight at study initiation: 300 mg/kg bw group: 173.0g±6.08; 2000 mg/kg bw group 1: 171.7g±4.93; 2000 mg/kg bw group 2: 175.7g±9.45;
- Fasting period before study: at least 16 hours
- Housing: Single housing in Makrolon cages, type III.
- Diet: VRF1(P); SDS Special Diets Services, 67122 Altrip, Germany
- Water: Tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): of 20- 24
- Humidity (%): 20- 80
- Photoperiod (hrs dark / hrs light): 12 h light and 12 h darkness.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 6 and 40 g/100 mL
- Amount of vehicle (if gavage): 5 mL/kg
- Justification for choice of vehicle: Good homogeneity in olive oil Ph.Eur.
- Form of administration: suspension
DOSAGE PREPARATION: For better handling the test substance was ground with mortar and pistil. The test-substance preparation was produced for each test group shortly before administration by stirring with a high speed homogenizer (Ultra-Turrax) and a magnetic stirrer. The homogeneity of the test-substance preparation during application was provided by stirring with a magnetic stirrer. - Doses:
- 300 and 2000 mg/kg
- No. of animals per sex per dose:
- 300 mg/kg: 3; 2000 mg/kg: 6
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Individual body weight determination shortly before administration (day 0), weekly thereafter and an the last day of observation. Recording of signs and symptoms several times on the day of administration, and at least once daily thereafter each workday for the individual animals. A check for any dead or moribund animal was made twice each workday and once on weekends and on public holidays.
- Necropsy of survivors performed: yes
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred in the six females administered with 2000 mg/kg bw and in the three females administered with 300 mg/kg bw.
- Clinical signs:
- Clinical Observation in the 2000 mg/kg test groups revealed impaired and poor general state, dyspnoea, piloerection, none and reduced feces, staggering, ataxia, chromodacryorrhea, lacrimation and smeared fur from hour 0 through to study day 3 after administration.
No clinical signs and findings were observed in the 300 mg/kg bw administration group. - Body weight:
- The mean body weight of the test groups increased throughout the study period.
- Gross pathology:
- There were no macroscopic pathological findings in the animals sacrificed at the end of the observation period.
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information
- Conclusions:
- Under the conditions of this study the oral LD50 in rats is > 2000 mg/kg bw.
- Executive summary:
In an acute toxic class method (OECD 423 guideline study, GLP) the test substance was administered to female Wistar rats oral gavage. One group of three female rats were exposed to 300 mg/kg bw followed by two groups of three female rats exposed to 2000 mg/kg bw. After an observation period of 14 days surviving animals were necropsied. No mortality was observed in all exposed animals. Impaired and poor general state, dyspnoea, piloerection, none and reduced feces, staggering, ataxia, chromodacryorrhea, lacrimation and smeared fur were observed in the 2000 mg/kg bw dose group. No clinical effects were observed in animals exposed to 300 mg/kg bw. The LD50 was therefore determined to be above 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.